Published: Apr 11, 2026
Written by Klarity Editorial Team
Published: Apr 11, 2026

If you’re struggling with Binge Eating Disorder (BED), you may be wondering whether you can access treatment through telehealth—especially medications that might help reduce binge episodes. The short answer is yes—and in 2025, telehealth access to BED treatment is more established than ever.
This comprehensive guide will walk you through everything you need to know about getting BED medication via telehealth: which medications are available, how federal and state laws support online prescribing, who can prescribe for you, and what to expect during your virtual evaluation.
Binge Eating Disorder is the most common eating disorder in the United States, characterized by recurring episodes of eating large quantities of food in a short period, feeling out of control during these episodes, and experiencing significant distress afterward—without the compensatory purging behaviors seen in bulimia.
To meet clinical criteria for BED, these episodes typically occur at least once a week for three months. The disorder affects people across all demographics and can lead to serious health complications including obesity, diabetes, and cardiovascular disease.
Effective BED treatment usually involves multiple components:
While therapy remains the gold standard, medications can play an important supporting role—and that’s where telehealth access becomes crucial for many people who face barriers to in-person care.
Only one medication—Vyvanse (lisdexamfetamine)—has FDA approval specifically for treating BED. However, Vyvanse is a controlled substance (Schedule II stimulant), which makes telehealth prescribing more complex and restricted under current federal regulations.
Instead, telehealth providers commonly prescribe two non-controlled medications that have shown effectiveness in reducing binge eating episodes, even though they’re used ‘off-label’ for this purpose:
Originally approved for seizures and migraine prevention, topiramate has been studied for BED treatment with promising results. Research suggests it may help reduce binge frequency and support weight management in some patients.
Key considerations:
FDA-approved for depression and smoking cessation, bupropion has also shown benefit in reducing binge eating episodes and associated depression.
Key considerations:
Both medications are non-controlled substances, which is the critical factor that makes them widely accessible via telehealth without the strict in-person requirements that apply to controlled medications.
Understanding the legal landscape helps explain why accessing BED medications online is straightforward in 2025-2026.
The Ryan Haight Act of 2008 is a federal law that restricts prescribing controlled substances via telehealth, generally requiring at least one in-person medical evaluation. However, this law does not apply to non-controlled medications like Topamax and Wellbutrin.
This means that at the federal level, there has never been a restriction on prescribing these BED medications via telehealth—provided the prescriber follows standard medical practices and is licensed in your state.
During the pandemic, the DEA created temporary rules allowing controlled substance prescribing via telehealth without in-person visits. These rules have been extended multiple times, most recently through December 31, 2026, while the DEA works on permanent regulations.
While this primarily affects controlled medications (like ADHD stimulants or anxiety medications), the extensions demonstrate federal commitment to maintaining telehealth access. For non-controlled BED medications, access remains fully open with no federal in-person requirements.
You can receive a prescription for Topamax or Wellbutrin via telehealth from any provider licensed in your state who conducts an appropriate evaluation. No federal law requires you to see a doctor in person first for these medications.
While federal law is permissive for non-controlled medications, individual states set their own telehealth standards. The good news: most states now allow fully remote prescribing for medications like those used for BED.
The majority of states—including California, New York, Texas, Florida, Michigan, Wisconsin, Delaware, and South Carolina—have no requirement for an in-person visit before prescribing non-controlled medications via telehealth.
In these states, your initial evaluation can be conducted entirely by video call, and you can continue treatment remotely as long as appropriate follow-up occurs.
California even explicitly allows asynchronous telehealth (like online questionnaires) to satisfy the ‘examination’ requirement, as long as it meets the standard of care.
A few states require periodic in-person follow-ups for ongoing telehealth treatment:
Alabama requires an in-person visit within 12 months if you’ve had more than four telehealth visits for the same condition. However, this visit can be with any collaborating provider—not necessarily your telehealth prescriber.
Georgia requires providers to ‘attempt’ an annual in-person examination for continued telemedicine care, though the initial evaluation can be done via telehealth if it’s equivalent to an in-person exam.
New Hampshire allows telehealth prescribing but requires at least one in-person visit every 12 months for continued treatment, even for non-controlled medications in some circumstances.
These requirements are generally manageable and shouldn’t prevent you from starting treatment via telehealth. Many patients can satisfy them with their primary care doctor or at a local clinic.
At Klarity Health, we navigate these state-specific requirements for you. Our providers are licensed in multiple states and familiar with local regulations. We accept both insurance and cash pay, offer transparent pricing, and maintain excellent provider availability—often with same-week appointments.
For patients in states requiring periodic in-person follow-ups, we can coordinate with your existing healthcare providers or help you find convenient local options for annual check-ins while managing your BED treatment primarily through our telehealth platform.
MDs and DOs can prescribe these medications via telehealth in all states, provided they’re licensed where you’re located.
Nurse Practitioners (NPs) can also prescribe Topamax and Wellbutrin for BED, but their level of autonomy varies by state:
Full Practice Authority States (34+ states plus DC): NPs can evaluate, diagnose, and prescribe independently without physician oversight. States that recently joined this group include:
In these states, you might see an NP for your entire BED treatment without any physician involvement.
Collaborative Practice States: In states like Texas, Florida, Georgia, and Alabama, NPs must work under a collaborative agreement with a physician. This doesn’t affect your care quality—it’s a behind-the-scenes regulatory requirement—but you might see both the NP’s and collaborating physician’s names on your prescription.
What matters for you: Whether you see an MD, DO, or NP through a telehealth service, you can receive the same quality BED treatment. The provider’s clinical expertise and your personal rapport matter more than their credential letters.
PAs can also prescribe these medications under varying levels of supervision depending on state law. Most telehealth platforms that employ PAs have the necessary oversight structures in place.
When you schedule a telehealth appointment for BED treatment, expect a thorough clinical evaluation—typically 30-45 minutes for an initial visit. Legitimate providers will:
Ask detailed questions about your eating behaviors:
Review your complete medical history:
Screen for contraindications:
Verify your identity and location: State laws often require confirming you’re physically located in a state where your provider is licensed. This isn’t invasive—it’s a legal requirement to ensure proper care.
You’ll receive and sign several forms:
Reputable providers will clearly explain that Topamax and Wellbutrin are being used ‘off-label’ for BED—meaning they’re FDA-approved medications prescribed for a use that isn’t their official indication. This is legal, common, and supported by clinical research.
If medication is appropriate for you, your provider will:
For non-controlled medications, providers can often authorize refills (up to 6-12 months depending on state law), but they’ll want regular check-ins to monitor your progress.
The telehealth industry learned important lessons from pandemic-era problems, including high-profile cases of inappropriate prescribing. Here’s how to ensure you’re getting safe, quality care:
✅ Thorough evaluations: Initial appointments are at least 20-30 minutes, not a 5-minute checkbox questionnaire
✅ Comprehensive approach: Discusses therapy, nutrition, and lifestyle changes—not just medication
✅ Clear follow-up plans: Schedules regular check-ins and provides easy ways to contact your provider
✅ Transparent pricing: Upfront about costs, insurance acceptance, and what’s covered
✅ Licensed providers: Clearly displays provider credentials and state licenses
✅ Proper pharmacy use: Sends prescriptions to regular pharmacies, not selling medications directly
🚩 Guaranteed prescriptions before evaluation: Legitimate providers can’t promise medication without examining you
🚩 Minimal questioning: A few yes/no questions aren’t sufficient for safe prescribing
🚩 Pressure tactics: Pushing you toward medication without discussing alternatives
🚩 Requests for payment to ‘guarantee’ prescription: Ethical providers charge for the visit, not the prescription outcome
🚩 Shipping medication directly: FDA-approved medications should come from licensed pharmacies
🚩 No follow-up: Safe treatment requires ongoing monitoring
Many states maintain prescription databases that track controlled substance prescriptions. While Topamax and Wellbutrin aren’t controlled and thus aren’t legally required to trigger a PMP check, many responsible providers will still review your medication history to:
This is good clinical practice, not a sign you’re being suspected of anything inappropriate.
While telehealth works well for many people, some situations require in-person evaluation:
If you have a history of anorexia or bulimia with purging behaviors: Wellbutrin is specifically contraindicated due to seizure risk. Providers should be extremely cautious and likely refer you to specialized in-person eating disorder treatment.
Active seizure disorder: Both medications can affect seizure threshold. You need close neurological monitoring that may not be appropriate via telehealth alone.
Pregnancy or breastfeeding: Topiramate carries significant fetal risks. Pregnant women should receive care coordinated between OB/GYN and mental health specialists, typically in-person.
Active suicidal ideation: While mild depression is treatable via telehealth, active suicidal thoughts require immediate in-person or crisis intervention.
Severe medical instability: If BED has caused acute health crises (uncontrolled diabetes, severe electrolyte imbalances, cardiac issues), you need in-person comprehensive medical evaluation.
Complex medication regimens: If you’re already on multiple psychiatric medications or have had adverse reactions to many medications, specialized in-person psychiatric care might be more appropriate.
Need for controlled substances: While Vyvanse is FDA-approved for BED, most telehealth providers don’t prescribe it due to stricter regulations on controlled substances. If your provider determines you’d benefit from a stimulant medication, you’ll likely need an in-person specialist referral.
Substance use concerns: Active alcohol use disorder is a relative contraindication for Wellbutrin (increased seizure risk). Significant substance use may require specialized addiction treatment alongside BED care.
Most insurance plans now cover telehealth visits at the same rate as in-person visits, thanks to pandemic-era policy changes that many insurers made permanent. However, coverage varies:
Medicare: Covers telehealth for mental health and many medical conditions, with some temporary flexibilities extended through 2026
Medicaid: Coverage varies by state but has generally expanded significantly
Private insurance: Most major insurers cover telehealth; check your specific plan for copays and any limitations
With insurance: Topamax (topiramate) and Wellbutrin (bupropion) are both available as generics, making them affordable for most insured patients. Copays typically range from $10-$30 per month.
Without insurance (cash pay):
These are among the more affordable psychiatric medications, especially compared to brand-name options.
If you don’t have insurance or prefer not to use it, many telehealth platforms offer cash-pay options. At Klarity Health, we provide transparent pricing for both insured and self-pay patients, with costs that are often comparable to or less than traditional in-person specialists when you factor in time and travel.
First 2-4 weeks: Close monitoring as you start medication and adjust to potential side effects. Expect a follow-up appointment within 2-4 weeks.
Months 2-3: Monthly check-ins to assess effectiveness, adjust dosing if needed, and monitor for adverse effects.
Ongoing care: Once stable, appointments might shift to every 2-3 months, though you’ll maintain regular contact through secure messaging or patient portals.
For topiramate:
For bupropion:
Reach out immediately if you experience:
Reputable telehealth platforms provide clear pathways for urgent communication—not just scheduled appointments.
Medication alone is rarely sufficient for BED recovery. The most effective approach combines:
Cognitive Behavioral Therapy (CBT): The gold-standard treatment for BED, helping you identify and change thought patterns and behaviors that trigger binge episodes.
Dialectical Behavior Therapy (DBT): Particularly helpful if emotional dysregulation contributes to binge eating. Teaches distress tolerance and emotion regulation skills.
Many telehealth platforms, including Klarity Health, can connect you with therapists who specialize in eating disorders—either on the same platform or through referrals.
Working with a registered dietitian who specializes in eating disorders can help you:
Peer support—whether through organizations like Overeaters Anonymous, NEDA support groups, or online communities—provides accountability and reduces isolation.
Your telehealth provider should discuss these complementary approaches and help you build a comprehensive treatment plan.
Federal level: The DEA extended COVID-era telehealth prescribing flexibilities for controlled substances through December 31, 2026. While this doesn’t directly affect non-controlled BED medications, it signals continued federal support for telehealth access.
State level: Recent expansions include:
New York (May 2025) adopted rules requiring in-person exams before prescribing controlled substances via telehealth, but this doesn’t affect non-controlled medications like Topamax and Wellbutrin.
The DEA is expected to finalize permanent telehealth prescribing rules by the end of 2026. While the focus is on controlled substances, the regulations will likely solidify the telehealth infrastructure that makes accessing all types of mental health and medical care easier.
For BED treatment with non-controlled medications, the trend is clearly toward expanded access and fewer barriers—not restrictions.
If you’re struggling with Binge Eating Disorder, telehealth offers a convenient, private, and effective way to access professional help. Here’s how to get started:
Look for telehealth platforms that:
Before your appointment:
The quality of your care depends on the information you provide. Share:
Providers can’t help with what they don’t know about.
If prescribed medication:
Medications for BED typically take several weeks to show full effects. Most people notice gradual reductions in binge frequency rather than immediate elimination. Stay in close contact with your provider during the initial weeks.
At Klarity Health, we understand that accessing mental health care—especially for conditions like Binge Eating Disorder—can feel overwhelming. We’ve designed our telehealth platform to remove common barriers:
Provider Availability: We maintain excellent provider availability with same-week and often same-day appointments, so you don’t wait weeks to start treatment.
Insurance & Cash Pay: We accept most major insurance plans and also offer transparent cash-pay pricing for those without insurance or who prefer not to use it.
Comprehensive Care: Our providers don’t just write prescriptions—we offer therapy referrals, ongoing monitoring, and coordinate with your other healthcare providers when needed.
State Expertise: Our team stays current on state-specific telehealth regulations, so you can be confident you’re receiving care that’s not only effective but fully compliant with local laws.
Privacy and Convenience: Meet with providers from your home, on your schedule, with the same clinical quality as in-person visits.
Whether you’re just starting to explore treatment options or you’ve been struggling with BED for years, our providers are here to help you develop a personalized treatment plan that works for your life.
Binge Eating Disorder is a real, serious medical condition—not a lack of willpower. And thanks to telehealth regulations that prioritize patient access while maintaining safety standards, effective treatment is more accessible than ever.
Medications like Topamax and Wellbutrin, combined with therapy and other supports, can significantly reduce binge episodes and improve your quality of life. The telehealth evaluation process is straightforward, safe, and designed with your wellbeing in mind.
If you’re ready to take the first step toward recovery, schedule a telehealth evaluation today. You deserve compassionate, evidence-based care—and you don’t have to travel to a specialist’s office to get it.
Ready to start your BED treatment journey? Book an appointment with Klarity Health today and meet with a licensed provider who can evaluate your symptoms and discuss whether medication, therapy, or a combination approach is right for you. With same-week availability and both insurance and cash-pay options, your path to recovery can start now.
Verified as of: January 4, 2026
DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications—these were never subject to the Ryan Haight Act restrictions on telemedicine.
States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, etc.) with latest information as of late 2025. State board sites and 2025 legislative updates were checked where available.
Sources Newer Than 2024: 80%+ of sources are from 2025 (many late-2025) or updated to 2025. Older sources (2024) were used only when confirmed still accurate by newer references.
Flagged for Follow-Up: Alabama and South Carolina NP scope changes (legislation was discussed in 2025 but final status unclear—assume no full independence yet pending confirmation). Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Verify any temporary state waivers for expiration/extension beyond 2025.
U.S. Department of Health and Human Services – ‘DEA Extends Telemedicine Prescribing Flexibilities Through December 31, 2026’ (January 2026). Official announcement of the fourth extension of COVID-era telehealth prescribing rules. www.hhs.gov
Sheppard Mullin Healthcare Law Blog – ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions’ (August 2025). Comprehensive legal analysis of state-by-state telehealth prescribing changes with citations to state laws and regulations. www.sheppardhealthlaw.com
Center for Connected Health Policy (CCHP) – ‘Online Prescribing State Laws & Reimbursement Policies Database’ (Updated November-December 2025). Authoritative aggregation of state telehealth laws with direct quotes from state regulations. www.cchpca.org
Health Jobs Nationwide Blog – ‘State-by-State Guide: Expanding Roles for PAs and NPs Updated 2025’ (2025). Analysis of nurse practitioner scope of practice changes across states, including recent legislative updates. blog.healthjobsnationwide.com
National Law Review – ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions’ (2024-2025). Legal review of telehealth policy developments including New York’s May 2025 final rule on controlled substance prescribing. natlawreview.com
Find the right provider for your needs — select your state to find expert care near you.